YGenHiVi: Evaluation of the POSOS Device for Iatrogenesis Detection in Clinical History? A Vignettes Study

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT05952193
Collaborator
Centre Hospitalier de Bourg en Bresse (Other), Saint Antoine University Hospital (Other), CHU de Rouen - Accueil (Other), CHU de Créteil (Other), Médipôle Lyon-Villeurbanne (Other), Centre Hospitalier Universitaire de Nice (Other), University Hospital, Montpellier (Other), University Hospital, Lille (Other), Centre Hospitalier de Niort (Other), Centre Hospitalier Régional Metz-Thionville (Other), University Hospital, Grenoble (Other), CHU de Reims (Other)
128
1
12.4
10.4

Study Details

Study Description

Brief Summary

This study is a multicenter evaluation of diagnostic performance using simulated clinical vignettes. It aims to test the effectiveness of the POSOS app in detecting drug-induced iatrogenesis in urgent medical situations, an issue of public health importance. Participating physicians, who are randomly assigned to either use or not use POSOS, are categorized based on their years of experience. Vignettes, including a mixture of complex, simple, and non-iatrogenesis cases, are assigned to these doctors. During the simulation, physicians respond to their respective vignettes on the YgheniVi platform, with responses recorded at two intervals (5 min and 15 min). The supervising physicians subsequently fill out an e-CRF, providing further data on the time spent, the number of medical research applications used, and the overall user experience of POSOS. A doctor/pharmacist pair then corrects the answers to the vignettes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
128 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the POSOS Device for Iatrogenesis Detection in Clinical History? A Vignettes Study
Actual Study Start Date :
Jun 21, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
seniority ≥3 years + POSOS

seniority ≥3 years without POSOS

seniority <3 years with POSOS

seniority <3 years without POSOS

Outcome Measures

Primary Outcome Measures

  1. the proportion of overall correct responses in each groups [5 minutes]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Not applicable as the study population is made up of clinical vignettes, there is no inclusion of patients.

  • The physicians included are emergency physicians, selected by convenience so as to have as many physicians (seniority of practice 3 years after thesis) as (seniority of practice less).

Exclusion Criteria:
  • Not applicable.

  • Simulations with technical faults will be excluded: (absence of the test doctor, internet access not working, PC malfunction, serious disruptions during the simulation).

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Amiens France 80480

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens
  • Centre Hospitalier de Bourg en Bresse
  • Saint Antoine University Hospital
  • CHU de Rouen - Accueil
  • CHU de Créteil
  • Médipôle Lyon-Villeurbanne
  • Centre Hospitalier Universitaire de Nice
  • University Hospital, Montpellier
  • University Hospital, Lille
  • Centre Hospitalier de Niort
  • Centre Hospitalier Régional Metz-Thionville
  • University Hospital, Grenoble
  • CHU de Reims

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT05952193
Other Study ID Numbers:
  • PI2023_843_0070
First Posted:
Jul 19, 2023
Last Update Posted:
Jul 19, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire, Amiens

Study Results

No Results Posted as of Jul 19, 2023